Check Before You Invest : Walpar Nutritions Ltd

Snapshot

Q.1 Which industry/sub-sector does Walpar Nutritions Ltd belong to?

Walpar Nutritions Ltd belongs to the Healthcare sector, operating specifically within the Pharmaceuticals & Drugs segment.

Q.2 Is Walpar Nutritions Ltd a good quality company?

Walpar Nutritions Ltd is a quality company, based on a 5-year financial track record.

Q.3 Is Walpar Nutritions Ltd undervalued or overvalued?

Walpar Nutritions Ltd appears Undervalued, as its key valuation ratios are below with their past averages.

Q.4 Is Walpar Nutritions Ltd a good buy now?

Walpar Nutritions Ltd is not a good buy now, based on weak price trend analysis suggesting prices may fall. However, you need to check its quality and valuation before making a decision

Performance Analysis

Q.1 Return on capital employed (ROCE) of Walpar Nutritions Ltd?

Walpar Nutritions Ltd Return on capital employed is 17.7% for FY-2025, which is above its 5-year historical median of 6.44%. The current ROCE is above its estimated weighted average cost of capital (WACC) of 14%, indicating value creation.

Q.2 Return on Asset of Walpar Nutritions Ltd?

Walpar Nutritions Ltd Return on Asset is 6.23%, which is above its 5-year historical median of 2.15%, indicating improved asset utilization efficiency.

Q.3 Return on Equity (ROE) of Walpar Nutritions Ltd?

Walpar Nutritions Ltd Return on equity is 11.95% for FY-2025, which is above its 5-year historical median of 5.37%, indicating the business is making better use of its shareholders capital.

Q.4 Gross Profit margin of Walpar Nutritions Ltd?

Walpar Nutritions Ltd Gross profit margin which is the profit after deduction of direct costs, is 4.7% for FY-2025, which is above its 5-year median of 3.3%, indicating increasing margins.

Q.5 Operating Profit Margin of Walpar Nutritions Ltd?

Walpar Nutritions Ltd Operating Profit Margin which is the profit after deduction of all operating costs, is 4.74% for FY-2025, which is above its 5-year median of 4.02% indicating increasing margins.

Q.6 Net Profit Margin of Walpar Nutritions Ltd?

Walpar Nutritions Ltd Net Profit Margin is 2.81% for FY-2025, is above with its 5-year median of 2.17%, indicating increasing margins.

	Current Level	5-year Historic Median
Gross Profit Margin	4.7	3.3
Operating Profit Margin	4.74	4.02
Net Profit Margin	2.81	2.17

Q.7 Debt to Equity ratio of Walpar Nutritions Ltd?

Walpar Nutritions Ltd Debt-to-Equity ratio is 0.00, which is lower with the industry average of 0.27, indicating lower debt levels in the industry.

Q.8 Debt to cash flow from operations of Walpar Nutritions Ltd?

Walpar Nutritions Ltd Debt to cash flow from operations is 0, which is at a healthy level.

Ownership & governance

Q.1 Promoter shareholding and pledge status of Walpar Nutritions Ltd?

Promoters hold 68.82% of the Walpar Nutritions Ltd, with 0.00% of their stake pledged, indicating no pledge risk.

Peer comparison (industry-wise, mcap)

Q.1 Revenue growth of Walpar Nutritions Ltd vs industry peers?

Walpar Nutritions Ltd revenue CAGR is 0.00%, compared to the industry median CAGR of 8.30%, indicating slower growth and losing its market share.

Profit Metrics

	Current Level	5-year Industry Median
Revenue Growth	-	8.3
Gross Profit Growth	68.1	14.7
Operating Profit Growth	61.4	11.4
Net Profit Growth	52.3	NAN

Operating Efficiency

	Current Level	5-year Industry Median
Asset Turnover	2.22	0.81
ROE	11.95	9.49
ROCE	17.7	11.91
Cash Conversion Cycle (days)	40.58	85

Valuation & price assessment

Q.1 Stock return of Walpar Nutritions Ltd over the last decade?

Over the last 3 year(s), the stock has delivered a CAGR of -19.86% based on the current price.

Q.2 What return has the stock given over the last decade?

	9Y	5Y	3Y	1Y
Share Price CAGR	-	-	-19.9%	-19.6%

Q.3 Valuation ratios of Walpar Nutritions Ltd vs historical?

The current P/E is lower that its historical median.

Q.4 How do the current valuation ratios compare with 5-year historical median and industry numbers?

Valuation Ratios	Current	5-year Historic Median	5-year Industry Median
Price to Earnings	20.52	53.82	31.09
Price to Book	2.32	2.85	2.85
Price to Sales	0.58	0.96	2.79
EV to EBITDA	11.29	26.65	15.87

Check more companies

6. Wockhardt

7. Pfizer

8. Piramal Pharma

9. Acutaas Chemicals

10. Astrazeneca Pharma I

Check trending companies

1. Force Motors Ltd.

2. KEI Industries Ltd.

3. Aadhar Housing Finance Ltd.

4. State Bank Of India

5. Power Finance Corporation Ltd.